CTOs on the Move

Advantia Health

www.advantiahealth.com

 
Advantia is transforming healthcare for all women - we`re setting a higher standard of care and convenience while reducing unnecessary costs. Compassion and value inspire everything we do. We take time to listen, answer questions completely, and offer helpful technology between visits so that our patients are empowered and at ease. Alongside coordinated care, Advantia is pioneering care models that align incentives with the best interests of women and their families.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Advantia Health raised $45M on 01/08/2020

Similar Companies

Dermatologists of Central States

DOCS Dermatologists of Central States is one of the largest dermatology practice groups in the United States. With over 155 providers spread across seven central states, we have been serving patients for over 40 years. Our focus is on medical, surgical...

NorthStar Clinical Communications

NorthStar Clinical Communications is a Washington Crossing, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Total e-Medical

Total e-Medical is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Boca Raton, FL. To find more information about Total e-Medical, please visit www.totalemedical.com

Lumeris

Lumeris is a value-based care managed services operator for health systems and providers seeking extraordinary clinical and financial outcomes. Lumeris aligns providers and payers across populations with technologies, processes, behaviors and information to achieve high-quality, cost-effective care with satisfied consumers — and engaged physicians. Lumeris with Essence Healthcare, its inaugural client with more than 60,000 Medicare members in Missouri and Illinois, has averaged a CMS rating of 4.5 Stars for the last ten years and produced the highest consumer and physician satisfaction scores in the industry along with significantly better clinical outcomes and lower costs.

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.